Phase 1 clinical trial of adoptive immunotherapy using “off-the-shelf” activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia
Michael Boyiadzis(UPMC Hillman Cancer Center), Mounzer Agha(UPMC Hillman Cancer Center), Robert L. Redner(UPMC Hillman Cancer Center), Alison R. Sehgal(UPMC Hillman Cancer Center), Annie Im(UPMC Hillman Cancer Center), Jing‐Zhou Hou(UPMC Hillman Cancer Center), Rafic Farah(UPMC Hillman Cancer Center), Kathleen Dorritie(UPMC Hillman Cancer Center), Anastasios Raptis(UPMC Hillman Cancer Center), Seah H. Lim(UPMC Hillman Cancer Center), Hong Wang(UPMC Hillman Cancer Center), Natalia Lapteva(Texas Children's Hospital), Zhuyong Mei(Baylor College of Medicine), Lisa H. Butterfield(UPMC Hillman Cancer Center), Cliona M. Rooney(Houston Methodist), Theresa L. Whiteside(UPMC Hillman Cancer Center)
Cited by 179
Abstract
Related Papers
No related papers found
Powered by citation graph analysis